IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation ...
IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Now how it works. Using the patient's remote control immediately prior to an MRI, the MRI technician can confirm that the lead and the implant are intact by performing a very simple check. This avoids ...
In February, the FDA approved Axonics third-generation implantable neurostimulator. And as a reminder, the third-generation neurostimulant has upgraded embedded software, which enhances the ...
* AXONICS MODULATION TECHNOLOGIES - FDA REVIEW OF LABELING EXPANSION EXPECTED TO COMPLETE IN EARLY Q4 Source text for Eikon: Further company coverage: ...
Competition in the sacral neuromodulation space continues to breed new options for patients with bladder and bowel dysfunction. Irvine, CA-based Axonics now has FDA approval for its recharge-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results